NuraLogix announces new capabilities to assess risk for fatty liver disease using a contactless health platform that measures vital signs and provides health risk assessments.
Researchers at the company have developed an artificial intelligence (AI) model that can use facial blood patterns to predict the risk of fatty liver disease (FLD).
Keith Thompson, Ph.D., Chief Medical Officer, NuraLogix, said: “This study demonstrates the potential of the platform to screen for FLD and help users intervene in the lifestyle changes needed to prevent ‘waterfall’ events such as liver failure. ”
The NuraLogix Anura contactless health platform can already capture over 30 medical-grade health vitals using video-enabled devices, including blood pressure, cardiac load, heart rate variability, and respiratory rate.
The platform uses traditional video cameras to extract facial blood flow information and combines it with AI model analysis in the cloud to obtain health information based on facial blood flow patterns.
It uses patented Transcutaneous Optical Imaging (TOI) technology to monitor the user’s health. This form of remote photoplethysmography (rPPG) automatically detects human faces, identifies key regions of interest, and extracts blood flow information. This is combined with powerful AI data models developed from her over 40,000 patients with multiple health conditions.
The new features add to Anura’s existing capabilities, including T2 Diabetes Risk Assessment, Cardiovascular Disease Risk, Depression Health Risk, and Hypertension Risk.
This solution has potential in many areas that could change the way chronic diseases are identified, managed and presented. In the future, we will be able to continuously monitor our health vitals simply by looking at our smartphones, mirrors, TV screens, or health kiosks. The Anura platform is hardware and platform agnostic and works with most digital consumer and his B2B health platforms on the market.
Artificial intelligence is increasingly being used to help detect and monitor health risks and diseases. This month, myGP users were granted access to her AI-powered skin scan technology in Autoderm, allowing her to check the health of her skin and detect potential conditions.
